The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 07, 2025
Filed:
Jan. 21, 2022
Applicant:
Beyondspring Pharmaceuticals, Inc., New York, NY (US);
Inventors:
Lan Huang, New York, NY (US);
George Kenneth Lloyd, New York, NY (US);
Ramon Mohanlal, New York, NY (US);
Assignee:
BeyondSpring Pharmaceuticals, Inc., New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/496 (2006.01); A61K 31/337 (2006.01); A61K 31/351 (2006.01); A61K 31/4745 (2006.01); A61K 31/664 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 33/243 (2019.01); A61K 45/06 (2006.01); A61N 5/10 (2006.01); A61P 35/00 (2006.01); A61P 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/496 (2013.01); A61K 31/337 (2013.01); A61K 31/351 (2013.01); A61K 31/4745 (2013.01); A61K 31/664 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 33/243 (2019.01); A61K 45/06 (2013.01); A61N 5/10 (2013.01); A61P 35/00 (2018.01); A61P 39/00 (2018.01);
Abstract
Disclosed herein are methods of reducing neutropenia that is caused by chemotherapy or radiation therapy by administering plinabulin to a subject.